News
Slideshow
Author(s):
Here's the latest multidisciplinary MS research published online first in the International Journal of MS Care.
FDA Accepts sNDA for Higher Dosing Regimen of Nusinersen for Spinal Muscular Atrophy
Episode 132: Aiding Diagnosis of Synucleinopathies Through SAAmplify-aSYN Biomarker Test
Comparison of CGRP-Targeting Treatments and OnabotulinumtoxinA Shows No Increased Cardiovascular Disease Risk
Neurology Unwrapped: 2024’s Most Intriguing Conversations
Pending FDA Decisions in Neurology to Watch in the First Half of 2025
NeuroVoices: Jacqueline A. French, MD, on Leveraging Neurostimulators to Advance Epilepsy Drug Development